The Liquid Biopsy and Tumor Progression in Breast Cancer
91 – 100 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
The distribution of circulating tumor cells is different in metastatic lobular compared to ductal carcinoma of the breast –long term prognostic significant
- Contribution to journal › Article
-
Mark
Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
- Contribution to journal › Article
-
Mark
Mammographic tumour appearance is related to clinicopathological factors and surrogate molecular breast cancer subtype
- Contribution to journal › Article
- 2019
-
Mark
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
- Contribution to journal › Article
-
Mark
Impact of systemic therapy on circulating leukocyte populations in patients with metastatic breast cancer
- Contribution to journal › Article
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
- Contribution to journal › Article
-
Mark
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
- Contribution to journal › Article
-
Mark
Artificial neural network models to predict nodal status in clinically node-negative breast cancer
- Contribution to journal › Article
-
Mark
Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence
- Contribution to journal › Article
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
- Contribution to journal › Article
